Ellington Credit Company (EARN)

Lumos Pharma Revenue

Ellington Credit Company had revenue of $10.58M in the quarter ending March 31, 2025, a decrease of -33.58%. This brings the company's revenue in the last twelve months to $35.89M, up 43.30% year-over-year. In the year 2024, Ellington Credit Company had annual revenue of $41.24M, down -63,546.15%.

• Revenue (ttm): $35.89M
• Revenue Growth: +43.30%
• P/S Ratio: 4.32
• Revenue / Employee: $239,287
• Employees: 150
• Market Cap: 212.59M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	41.24M	41.31M	-63,546.15%
Dec 31, 2023	-65.00K	-84.65M	-100.08%
Dec 31, 2022	84.58M	55.43M	190.14%
Dec 31, 2021	29.15M	28.68M	6,089.38%
Dec 31, 2020	471.00K	13.44M	-103.63%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.